You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 160 No. 12, June 26, 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Special Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (44)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Arrhythmias
 •Alert me on articles by topic

Practical Guidelines for Clinicians Who Treat Patients With Amiodarone

Nora Goldschlager, MD; Andrew E. Epstein, MD; Gerald Naccarelli, MD; Brian Olshansky, MD; Braman Singh, MD; for the Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology

Arch Intern Med. 2000;160:1741-1748.

Amiodarone has become an important drug for the treatment of supraventricular and ventricular arrhythmias, in short-term inpatient and outpatient settings. It may also have a role in affecting outcome in patients at high risk for arrhythmic events and sudden death; its place among available therapies is being established in clinical trials.


From the Cardiology Division, University of California, San Francisco, San Francisco General Hospital.


RELATED LETTER

Amiodarone-Induced Hyperthyroidism
Bernard Goichot, Fabienne Grunenberger, Jean-Louis Schlienger, and Nora Goldschlager
Arch Intern Med. 2001;161(2):295.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Archives of Internal Medicine Reader's Choice: Continuing Medical Education
Arch Intern Med. 2000;160(12):1879-1880.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The usefulness of 99mTc-sestaMIBI thyroid scan in the differential diagnosis and management of amiodarone-induced thyrotoxicosis
Piga et al.
Eur J Endocrinol 2008;159:423-429.
ABSTRACT | FULL TEXT  

Characteristics of the amiodarone-warfarin interaction during long-term follow-up
Lu et al.
Am J Health Syst Pharm 2008;65:947-952.
ABSTRACT | FULL TEXT  

Prescribing Amiodarone: An Evidence-Based Review of Clinical Indications
Vassallo and Trohman
JAMA 2007;298:1312-1322.
ABSTRACT | FULL TEXT  

Amiodarone for Atrial Fibrillation
Zimetbaum
NEJM 2007;356:935-941.
FULL TEXT  

Results From the Loire-Ardeche-Drome-Isere-Puy-de-Dome (LADIP) Trial on Atrial Flutter, a Multicentric Prospective Randomized Study Comparing Amiodarone and Radiofrequency Ablation After the First Episode of Symptomatic Atrial Flutter
Da Costa et al.
Circulation 2006;114:1676-1681.
ABSTRACT | FULL TEXT  

Best practice in primary care pathology: review 4
Smellie et al.
J. Clin. Pathol. 2006;59:893-902.
ABSTRACT | FULL TEXT  

Improving Laboratory Monitoring at Initiation of Drug Therapy in Ambulatory Care: A Randomized Trial
Raebel et al.
Arch Intern Med 2005;165:2395-2401.
ABSTRACT | FULL TEXT  

Is There a Role for Maintaining Sinus Rhythm in Patients with Atrial Fibrillation?
Zimetbaum and Josephson
ANN INTERN MED 2004;141:720-726.
ABSTRACT | FULL TEXT  

Effectiveness of Amiodarone for Conversion of Atrial Fibrillation to Sinus Rhythm: A Meta-analysis
Letelier et al.
Arch Intern Med 2003;163:777-785.
ABSTRACT | FULL TEXT  

Amiodarone-Induced Hyperthyroidism
Goichot et al.
Arch Intern Med 2001;161:295-295.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.